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Summary 
Given the significant impact that psychosocial factors and epilepsy treatments can have on 
the health-related quality of life (HRQOL) of individuals with epilepsy and their families, 
there is great clinical interest in the role of psychological evaluation and treatments to 
improve HRQOL and comorbidities. Therefore, the ILAE charged the Psychology Task 
Force with the development of recommendations for clinical care based on evaluation of the 
evidence from their recent Cochrane review of psychological treatments in individuals with 
epilepsy.  The literature search for a recent Cochrane review of Randomized Controlled 
Trials (RCTs) investigating psychological treatments for individuals with epilepsy constitutes 
the key source of evidence for this article. In order to provide practical guidance to service 
providers, we provide ratings on study research designs based on 1) the American Academy 
of Neurology’s (AAN) Level of Evidence (LOE) system and 2) the Grading of 
Recommendations, Assessment, Development and Evaluation (GRADE) system. This paper 
is the culmination of an international collaboration process involving pediatric and adult 
psychologists, neurologists, psychiatrists and neuropsychiatrists. The process and conclusions 
were reviewed and approved by the ILAE Executive Committee. The strongest evidence for 
psychological interventions was identified for the most common mental health problems, 
including depression, neurocognitive disturbances, and medication adherence. Psychological 
interventions targeting the enhancement of HRQOL and adherence and a decrease in 
comorbidity symptoms (anxiety, depression) should be incorporated into comprehensive 
epilepsy care. There is a range of psychological strategies (i.e., CBT and mindfulness-based 
therapies), which show promise for improving the lives of persons with epilepsy, and clinical 
recommendations are provided to assist epilepsy health care providers in treating the 
comorbidities and challenges associated with epilepsy and its treatments.  
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Key points 
• There are no previous specific recommendations for clinical practice based on the 
quality of the evidence for psychological treatments in patients with epilepsy  
• Ratings on study research designs were based on the American Academy of 
Neurology’s (AAN) Level of Evidence (LOE) system  
• Evidence-based recommendations were based by the Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE) system 
• The best evidence of effectiveness of psychological interventions was identified for 
depression, medication non-adherence, and neurocognitive disturbances.  
• Evidence supports that psychological therapies should be considered in the treatment 
of individuals with epilepsy to improve HRQOL and comorbidities.  
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1. Introduction 
Among the treatment tools for individuals with epilepsy, which include medication, diet, 
surgery, neuromodulation and psychological interventions, the latter most specifically aim to 
improve health-related quality of life (HRQOL). Individuals with epilepsy have a lower 
HRQOL than healthy individuals and individuals with other chronic diseases1. Even a single 
seizure is associated with reduced HRQOL2. Several factors contribute to poor HRQOL, 
especially when seizure freedom cannot be achieved, including medication side effects3, 4, 5, 
the number of anti-epileptic drugs (AEDs)4, 6, psychological symptoms (e.g., depression7, 8; 
and psychosocial difficulties (e.g., unemployment)9.  
Given the significant impact that psychosocial factors and epilepsy treatments can have 
on the HRQOL of individuals with epilepsy and their families, there is great clinical interest 
in the role of psychological evaluation and treatments to improve HRQOL. While several 
recent systematic and meta-analytic reviews of psychological treatments for individuals with 
epilepsy have been conducted10, 11, 12, 13, and consensus statements regarding 
psychological/psychiatric care for individuals with epilepsy have been published14, 15, specific 
recommendations for clinical practice based on the quality of the evidence for psychological 
treatments have not yet been developed.  
Therefore, the ILAE charged the Psychology Task Force with the development of 
recommendations for clinical care based on the evaluation of the evidence from their recent 
Cochrane review of psychological treatments to improve HRQOL in individuals with 
epilepsy12, 13. This paper is the culmination of a process of international collaboration 
involving pediatric and adult psychologists, neurologists, psychiatrists and neuropsychiatrists. 
The process and conclusions were reviewed and approved by the ILAE Executive 
Committee. The findings are intended for health care practitioners around the world. 
2. Method of evaluating the quality of for psychological treatments 
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2.1 Operational definition of psychological treatments 
“Psychological treatment” refers to a broad range of interventions for children and adults 
that encompass psychological or psychiatric non-pharmacological interventions for 
individuals, families and groups, as well as self-/family management, adherence and 
educational interventions (see Table 1). Intervention elements may be administered on their 
own or in combination. While some intervention elements are universally applicable, other 
elements address epilepsy and seizures more specifically. Interventions can target specific 
mental health disorders (anxiety, depression) or particular behaviors related to the 
management of epilepsy (adherence, coping). Even though differences in theoretical 
underpinnings and treatment targets limit the scope of comparisons11, there is overlap among 
the psychological treatments that can be applied to individuals with epilepsy.  
2.2 Source of evidence for recommendations 
The literature search for a recent Cochrane review of Randomized Controlled Trials 
(RCTs) investigating psychological treatments for individuals with epilepsy constitutes the 
key source of evidence for this article12, 13. While the Cochrane review focused on HRQOL 
and therefore excluded studies that did not include HRQOL as an outcome parameter, the 
present evidence-based recommendations included all RCTs investigating psychological 
interventions in individuals with epilepsy (figure 1).  
2.3 Method of evaluation  
In order to provide practical guidance to service providers, we provide ratings on study 
research designs based on 1) the American Academy of Neurology’s (AAN) Level of 
Evidence (LOE)16 system and 2) the Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) system17, 18. GRADE has been modified by Tolin et 
al. (2015) to include three levels (very strong, strong, and weak recommendation) for 
evaluation of the quality of evidence for RCTs in the clinical psychology literature19. Using 
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Tolin’s three levels (see Table 2), we evaluate the quality of evidence for psychological 
treatments for specific disorders (e.g., depression, anxiety) in addition to seizure outcomes, 
adherence, and epilepsy education and provide clinical recommendations for use of indicated 
treatments. If the evidence base for a given treatment is of low quality or lacking entirely, we 
highlight the need for further research in this area. We also provide a brief overview of 
treatment delivery, including options for resource-poor settings, as well as service 
considerations including recommendations for inpatient and outpatient treatment facilities 
and for training. 
2.4 Notable considerations 
Psychological treatments tend to be complex multicomponent interventions, i.e., several 
intervention components may be incorporated in diverse therapeutic approaches (e.g., 
education plus skills training) and studies with different treatment targets and, therefore, the 
same intervention components will be mentioned in various sections throughout this article. 
Special issues relating to pediatric populations will be included in each subsection. Level 3 
and Level 4 Specialized Epilepsy Centers are required to have a psychologist and social 
worker as part of their centers; however, which psychosocial services are offered are not 
specified20. Because psychological treatment delivery varies within and across countries and 
settings, we will mostly refer to “mental health care providers” without specifying their 
professional groups. Mental health care providers can include psychiatrists, psychologists, 
psychotherapists, licensed clinical social workers, neurologists with therapy training, 
neuropsychiatrists, and psychiatric nurses, among other mental health professionals. Cultural 
issues and differences that may affect implementation, and utilization will be mentioned; 
however, an elaborate discussion of cultural considerations and implications is beyond the 
scope of this paper. 
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The authors are aware of the challenges of clinical translation marked by the gap between 
ideal care and real care constraints in busy clinical settings, in which trained staff often 
necessary to deliver evidence-based interventions are lacking. However, it is relevant for all 
providers to focus on early identification and prevention of comorbidity, which could be 
time-and cost-effective, as HRQOL is a significant predictor of healthcare charges in 
epilepsy, with poorer HRQOL predicting greater healthcare charges21, 22, 23.  
3. Available evidence for psychological treatment across the epilepsy spectrum: 
Relevance to clinical practice and recommendations 
3.1 Evidence-based screening: Selecting patients for psychological treatment in the 
clinical setting  
3.1a Evaluation of the evidence for psychological screening. Psychological disorders 
are at least twice as common in individuals with epilepsy than the general population24, 25; 
therefore, standard screening procedures for patients newly diagnosed with epilepsy, as well 
as for patients with chronic epilepsy, should be integrated into routine epilepsy care15, 21, 26. 
Symptom screening assists in the identification of individuals who may benefit from 
psychological treatments. To address the issue, the AAN has included screening for 
psychiatric or behavioral disorders at each epilepsy encounter as a new quality measure for 
the delivery of optimal care and better outcomes for individuals with epilepsy27.  
Epilepsy-specific measures are now available to evaluate psychosocial functioning, 
including depressive symptoms and HRQOL. For example, the six-item self-report survey, 
Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), is an epilepsy-specific 
screening tool for major depression28 and its feasibility has been demonstrated in a routine 
clinical setting29. Annual use of the NDDI-E has previously been recommended by the ILAE 
neuropsychiatric commission26. It has been validated in many languages, is freely available, 
and has been tailored for use in young people (NDDI-E-Y)30.  
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Screening measures for other aspects of psychological functioning (e.g., HRQOL, AED 
side effects) may provide beneficial information regarding patient well-being. 
Psychometrically sound and free epilepsy specific HRQOL tools include the QOLIE adult 
(QOLIE-10, QOLIE-31, QOLIE-89) and adolescent (QOLIE-48) measures31, 32 and the newer 
PedsQL Epilepsy Modules33, 34. Parent-proxy report of their child’s HRQOL can also be 
obtained via the Quality of Life in Childhood Epilepsy questionnaire (4-18 years old)35, 36. 
Additionally, the assessment of psychiatric/psychological symptoms at baseline can inform 
the choice of an AED, given that a history of psychological symptoms increases the 
vulnerability to subsequent behavioral/emotional side effects37, 38. Subsequently this baseline 
information can help determine if psychological symptoms arising during the course of 
treatment could be an AED side effect or an exacerbation of a premorbid or comorbid 
psychological disorder. Continued assessment of AED side effects over the course of 
epilepsy can inform changes to medications and/or alternative treatments (e.g., diet) and is 
important to consider at each epilepsy visit given the relationship between side effects, 
adherence, and HRQOL39. Standardized evaluation of side effects is available through use of 
the Pediatric Epilepsy Side Effects Questionnaire (PESQ)40 and the Liverpool Adverse Event 
Profile41, 42. 
3.1b Considerations for pediatric populations. Multi-informant screening is ideal for 
pediatric populations. While children are often better reporters of their own internalizing 
symptoms43, caregivers can provide a unique and beneficial perspective for some 
behaviors/deficits, such as executive functioning and oppositional or hyperactive behaviors44. 
Caregivers are also critical reporters when children have cognitive impairment developmental 
delays, or are too young to provide valid responses.  
3.1c Recommendations for psychological screening. Psychological screening is 
indicated given the high prevalence of mental health disorders in individuals with epilepsy. 
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According to the AAN practice guideline, patients with epilepsy should complete mental 
health screenings as part of routine epilepsy care27. Specific clinical recommendations 
include: 
1. Each epilepsy visit should include, at a minimum, a clinical question regarding mental 
health and quality of life. Screening is encouraged at epilepsy diagnosis, prior to and 
following AED initiation or changes and at routine time intervals (e.g., yearly). 
2. Practitioners should consider multi-informant screenings for children and also for 
adults, when indicated and available.  
3. A measure of psychological functioning should be administered prior to AED 
initiation and over the course of AED treatment.  
4. Practitioners should consider including a standardized evaluation of AED side effects.  
5. Practitioners are encouraged to consider a measure of HRQOL. 
6. If screening identifies significant symptoms or a problem, patients should undergo a 
formal mental health assessment to inform the selection of the appropriate treatment 
elements based on individual needs. Family members may provide key details of past 
events during this evaluation. 
 
3.2 Psychoeducation for patients, parents and caregivers 
Psychoeducational interventions involve the dissemination of knowledge and education 
regarding seizures, treatments, comorbid conditions, and lifestyle challenges. While most 
psychological interventions involve an aspect of education, this next section is reserved 
solely for interventions that focus primarily on education and not on the development of 
behavioral, cognitive, or meditation skills. 
3.2a Evaluation of the evidence for psychoeducational interventions. According to 
several national guidelines (e.g., Scottish Intercollegiate Guidelines Network, National 
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Institute of Clinical  Health and Care Excellence, United Kingdom, American Epilepsy 
Society), additional personalized information on treatment, possible outcomes, and specific 
risks must be provided to patients and families following an epilepsy diagnosis. Patients may 
experience challenges with adjustment to and worries about the epilepsy diagnosis after 
learning about potential legal, psychosocial and health ramifications45. Additionally, research 
indicates that individuals with epilepsy and/or their caregivers frequently misunderstand basic 
information about epilepsy, including knowledge about their diagnosis, seizure precipitants or 
triggers, purpose and potential side effects of AEDs, safety concerns, and the risks of 
seizures46, 47, 48, 49, 50. A large amount of the variance in HRQOL is explained by individuals’  
perceptions of their illness51, 52, and educational interventions may modify illness perceptions 
and improve an individual’s HRQOL. Therefore, it is prudent to follow-up the initial 
communication of an epilepsy diagnosis with (psycho-) education about seizures, treatments 
and their side effects, comorbid conditions, and self-management and quality of life issues26. 
Indeed, the AAN recommends providing personalized epilepsy safety information and 
education on a yearly basis27.  
Of the 15 RCTs investigating educational interventions, four studies were level of 
evidence (LOE) II53, 54, 55, 56, four studies57, 58, 59, 60 were LOE III, and seven studies61, 62, 63, 64, 
65, 66, 67 were LOE IV. All four LOE II studies reported improvements in their various primary 
outcomes: medication adherence53, epilepsy knowledge and satisfaction with information and 
support54, medication-related problems54, and HRQOL56. The LOE II studies investigated 
psychoeducational interventions that were delivered by specialized epilepsy nurses or trained 
medical doctors to individuals and included personalized information during routine visits or 
a general information package during a series of scheduled sessions.  
3.2b. Psychoeducational interventions for epilepsy receive a GRADE 
recommendation of STRONG (Table 3). There is moderate- to high-quality evidence that 
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psychoeducational interventions produce a clinically meaningful improvement in health 
related outcomes in individuals with epilepsy, including medication adherence, satisfaction 
with information and support, and HRQOL. 
3.2c Considerations for pediatric populations. Clinicians are encouraged to take into 
consideration the developmental abilities of children and level of understanding when 
discussing an epilepsy diagnosis with children and their families. Material should be 
presented in child-friendly terms with pictorial representations when possible or game-based 
formats. Depending on the child’s developmental level and chronological age, clinicians may 
wish to discuss some aspects of epilepsy with caregivers only (e.g., SUDEP).  
3.2d Specific clinical recommendations for epilepsy psychoeducation include: 
1. Each patient with epilepsy should receive psychoeducation. 
2. Because a diagnosis of epilepsy may create fear and shock in individuals and/or 
families, a follow up to the initial diagnosis is recommended to provide specific 
details regarding psychoeducation for a particular patient’s epilepsy symptoms, 
characteristics, and needs. 
3. Psychoeducation may focus on seizure knowledge and treatments, information needs 
and support, and/or comorbid conditions. 
4. Psychoeducation may be provided individually or in a group setting. 
5. Psychoeducation should be provided to patients with consideration for their 
developmental level, health literacy, and information and support needs. 
6. Clinicians are encouraged to select an evidence-based educational intervention that 
suits the needs of their patients (adult vs child, group vs individual) and to assess pre- 
and post- outcomes (e.g., knowledge) to monitor whether their patients are learning 
from the intervention.  
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7. Clinicians are encouraged to continue to routinely assess their patient’s needs for 
psychoeducation about epilepsy, its treatments, and comorbid conditions across the 
lifespan. 
3.3. Depressive symptoms 
There is substantial evidence supporting the idea of a bidirectional relationship between 
epilepsy and depression. Shared neurobiological mechanisms, for example lesion of mesial 
temporal structures and hippocampus volume loss68 shed light on the reasons for their co-
existence and interlinking relationship. Depression may predate the onset of epilepsy: A 
history of depression is associated with a 2- to 4-fold increase in the risk for an unprovoked 
seizure69, 70, 71. Depression can also be a psychological reaction to epilepsy, and it is a 
significant predictor of seizure outcomes with pharmacological and surgical treatments72, 73. 
There is newer evidence for specific clusters of depressive symptoms in persons with 
epilepsy, with the more common cluster consisting of a cognitive phenotype (e.g., self-critical 
cognitions, such as ineffectiveness)74.   
3.3a Evaluation of the evidence for interventions for depressive symptoms. Nine 
RCTs investigated psychological interventions for individuals with epilepsy with depression 
symptoms75, 76, 77, 78, 79, 80, 81, 82, 83 or as a preventative intervention for clinical depression in 
patients with subthreshold depressive symptoms84. The following seven studies measured 
depressive symptoms as secondary outcome: Four RCTs investigated psychological 
interventions85, 86, 87, 88, one RCT investigated a self-management89 and two RCTs 
investigated educational programs55, 65. 
Of these 15 studies, one study was LOE I84 (84), five studies were LOE II55, 75, 76, 79, 86, 89, 
two studies were LOE III78, 85 and the remaining eight studies were LOE IV53, 65, 77, 81, 82, 83, 87, 
88. Most LOE I and II studies reported significant reduction in depressive symptoms except 
for one depression-specific intervention LOE II study that reported a reduction in suicidal 
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ideation but no other significant changes on a generic depression scale75, 76 and the 
educational program55 that did not find any significant changes in depressive symptoms. The 
highest level of evidence pertains to skill-based training and behavioral interventions. 
Techniques comprised behavioral and social activation, problem solving and goal setting 
skills, training of social competencies, and identifying social support. These were particularly 
effective in addressing behavioral symptoms of depression and its associated limitations, such 
as social withdrawal, hypersomnia, physical inactivity, and unemployment75, 76, 84 (Table 4).  
3.3b Interventions for depressive symptoms in epilepsy receive a GRADE 
recommendation of STRONG (Table 4): There is moderate- to high-quality evidence that 
skill-based and behavioral psychological interventions produce a clinically meaningful effect 
on depressive symptoms, including suicidal ideation in individuals with epilepsy. 
3.3c Considerations for pediatric populations. There are limited data for the treatment 
of depression or depressive symptoms in pediatric epilepsy populations84, thus clinicians are 
encouraged to base treatment on the results of treatment trials conducted with children with 
depression in non-epilepsy populations90. Treatment may include psychoeducation to children 
and family as well as cognitive-behavioral therapy for children90, and most child focused 
depression protocols include strong family involvement in treatment (e.g., encouragement of 
mastery of skills). Notably, similar to adults, negative cognitions (ineffectiveness) may be 
more relevant than mood symptoms in youth with epilepsy, and interventions should target 
such symptoms91. Those who have risk factors for depression (e.g., family history of mood 
disorders, coexisting medical condition, psychosocial adversities) should be evaluated by 
clinicians at regular intervals92 for the prevention of clinical depression, early diagnosis, and 
treatment.   
3.3d Specific clinical recommendations for depressive symptoms include: 
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1. Depression should be assessed in routine epilepsy care following epilepsy diagnosis 
regardless of drug-responsiveness. 
2. Psychological interventions can be provided individually or in a group format. 
3. Treatment components may include behavioral intervention (e.g., social activation) 
and skill-based interventions (e.g., problem solving, social skills training). 
4. Treatment outcomes should be monitored using standardized inventories/rating scales.   
3.4 Treatment non-adherence and self-management 
Adherence is defined as the extent to which a person’s behavior coincides with medical or 
health advice93. In contrast, self-management is defined as the interaction of health behaviors 
and related processes that patients and families engage in to care for a chronic condition94. 
AED non-adherence ranges from 25-50%95, 96 in adults and 43-58%39, 97 in children with 
epilepsy. The consequences of non-adherence can be severe, including continued seizures39, 
98, poor HRQOL99, higher healthcare costs and utilization100, pharmacoresistence101, and even 
death102.  
3.4a Evaluation of the evidence for interventions for adherence and self-
management. Three RCTs investigated psychological interventions specifically aiming at 
increasing medication adherence103, 104, 105. Two studies investigated self-management 
interventions that measured medication adherence as a secondary outcome106, 107. Two 
studies104, 107 were LOE II, and the three remaining studies were LOE IV103, 105, 106. 
Significant results were reported for the LOE II pediatric adherence intervention while no 
significant changes were reported for the self-management program. Thus, the highest level 
of evidence pertains to education and teaching families of children with epilepsy about 
problem solving strategies. 
3.4b Adherence/Self-management interventions for epilepsy receive a GRADE 
recommendation of STRONG (Table 5): There is moderate- to high-quality evidence that 
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multi-component interventions that include education and problem-solving produce a 
clinically meaningful effect on medication adherence in children with epilepsy.  
3.4c Considerations for pediatric populations. Parents are encouraged to partner with 
the children and adolescents to manage the treatment regimen, including supervision around 
taking AEDs and avoidance of seizure triggers. Parental involvement can aid in ensuring that 
adherence does not decline in adolescents, a vulnerable developmental period. Technology-
focused adherence solutions may be particularly salient for adolescents108.  
3.4d Specific clinical recommendations for adherence/self-management include: 
1. Adherence should be assessed during routine clinical practice in a non-judgmental 
and open dialogue 
2. Clinicians are encouraged to assess barriers to adherence and problem-solve ways to 
improve adherence 
3. Use of technology focused solutions that enhance reminders and that may be well-
received and beneficial in establishing good adherence behaviors 
3.5 Seizures  
The aim of non-pharmacological seizure management techniques is to increase life 
quality as well as decrease seizure frequency and/or duration. Seizure management 
techniques could pragmatically be divided into three different approaches: 1) interventions to 
influence the consequences of seizures, e.g. mindfulness training on awareness and non-
judgmental acceptance of seizure-related physical symptoms, 2) interventions to affect the 
onset of seizures, e.g. discrimination of seizure triggers through a functional analysis of 
individual seizure development, lifestyle recommendations for stress coping, and 3) 
techniques to abort ongoing seizures, e.g. aura interruption techniques i.e. countermeasures to 
stop seizures from developing109, 110, 111, 112.  
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3.5a Evaluation of the evidence for interventions for seizure-related outcomes. Four 
RCTs investigated psychological interventions aimed to primarily decrease seizure 
frequency88, 113, 114, 115, 116. Five studies investigated psychological interventions75, 76, 82, 86, 109, 
110 and two studies58, 59 investigated an educational program that targeted non-seizure 
outcomes and included seizure frequency as a secondary outcome. Two studies75, 76, 86 were 
LOE II, three studies were LOE III58, 59, 113, the remaining six studies were LOE IV82. 88, 110, 
109, 114, 115, 116. A significant decrease in seizure frequency was reported in one LOE II study86 
that focused on mindfulness training together with a set of lifestyle recommendations that 
facilitated coping with seizure-related disturbances and stressful situations; and in one of the 
two educational programs58 that were both rated LOE III. Therefore, the highest level of 
evidence pertains to mindfulness-based therapies as well as lifestyle recommendations that 
facilitated stress coping. These allow patients to notice and acknowledge their emotional 
processes and physical symptoms related to their seizures, so as to facilitate acceptance and 
coping.  
3.5b Psychological interventions for seizure-related outcomes receive a GRADE 
recommendation of WEAK (Table 6): The evidence is inconclusive, suggesting an 
important area for future research. While there is moderate- to high-quality evidence that 
mindfulness-based therapies and lifestyle modifications that focus on improving HRQOL 
produce a clinically meaningful effect on seizure frequency in individuals with epilepsy, there 
is also evidence that CBT–based interventions focused on improving depressive symptoms do 
not have a clinically meaningful effect on seizure-related outcomes in individuals with 
epilepsy. 3.5c Considerations for pediatric populations. The development of psychological 
seizure management techniques may have to involve an assessment of the child’s family 
background and family dynamics99. Since parents and teachers may observe pre-seizure 
events, they may be taught to reinforce stress reduction and other healthy behaviors1114, 115.  
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3.5d Specific clinical recommendations for seizure-related outcomes include: 
1. Clinicians are encouraged to inquire about their patients’ interest in learning 
mindfulness training on awareness and non-judgmental acceptance of seizure-related 
physical symptoms 
2. Clinicians should provide education to patients and family members on the 
interlinking relationship between psychological factors and seizures, and therefore 
psychological treatments could be included as part of the epilepsy care. 
3. Clinicians are encouraged to investigate into details of seizure development (e.g. 
seizure precipitants, coping) and to make lifestyle recommendations relevant to 
individual patient. 
4. Mindfulness training designed for patients with epilepsy should be an adjunctive 
treatment option where resources allowed. 
3.6 Anxiety 
Panic and generalized anxiety are more frequent in adults and older adolescents with 
epilepsy than in the corresponding general population and may have a marked negative 
impact on the HRQOL117. In the assessment of anxiety disorders clinicians need to consider 
the temporal relationship of anxiety symptoms and seizures. This subsection focuses on 
interictal anxiety symptoms that may be related to a fear of future seizures as well as fears 
epilepsy-related consequences (psychosocial worries) and complications (such as injury, 
brain damage, memory impairment). The anticipatory anxiety about seizures may also take 
the form of seizure phobia, which may lead to maladaptive avoidance and isolation. It is, 
however, important to note that equally disabling anxiety symptoms (e.g., social phobia, 
generalized anxiety) may also occur separately from seizure-related worries and are also 
important to address 118. Perceived stigma is a risk factor for increased anxiety, which, again, 
illustrates the interrelatedness of psychological issues119, 120.  
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3.6a Evaluation of the evidence for interventions for anxiety symptoms. Only one 
RCT investigated a psychological intervention specifically aiming to decrease anxiety 
symptoms82. Four studies investigating psychological interventions77, 78, 86, 87, one study a 
self-management89 and one an educational program55, measured anxiety symptoms as a 
secondary outcome. Three studies55, 86, 89 were LOE II, and one study78 was LOE III, while 
the remaining three studies were LOE IV77, 82, 87. Of all LOE II studies, only the 
psychological intervention that measured anxiety symptoms as a secondary outcome reported 
a significant decrease in anxiety symptoms86. Hence the highest level of evidence pertains to 
the implementation of mindfulness exercises that may facilitate the process of awareness, 
experience, and finally acceptance of feelings of anxiety.  
3.6b Interventions for anxiety symptoms in epilepsy receive a GRADE 
recommendation of WEAK (Table 4): The evidence is somewhat inconclusive, suggesting 
this is an important area for future research. While there is moderate- to high-quality 
evidence that mindfulness-based interventions produce a clinically meaningful effect on 
anxiety symptoms in individuals with epilepsy, several other moderate to high quality studies 
did not demonstrate a meaningful effect. Notably, in many of these interventions, anxiety was 
a secondary outcome. 
3.6c Considerations for pediatric populations. Many parents refer to the experience of 
their child’s first seizure as traumatic which may lead to anxieties concerning the condition57. 
As a consequence, children may develop a fear of seizures by observing anxious parental 
reactions121. Psychological interventions that aim at alleviating anxiety in children may also 
have a secondary goal of addressing parents’ fear of seizures114, 115. Similar to depression, 
caregiver involvement in encouragement of skill rehearsal is important to skill mastery in 
children. 
3.6d Specific clinical recommendations for anxiety symptoms include: 
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1. Clinicians are encouraged to asses interictal anxiety symptoms that may be related to 
a fear of future seizures and fear of epilepsy-related complications  
2. Complex psychosocial worries, such as perceived stigma, may exacerbate symptoms 
of anxiety, and should be evaluated and addressed.  
3. The highest level of evidence pertains to the implementation of mindfulness exercises 
that may facilitate the process of awareness, experience, and finally acceptance of 
feelings of anxiety. Therefore, health care providers are encouraged to refer patients 
with anxiety symptoms for mindfulness-based interventions to alleviate their anxiety 
symptoms. 
3.7 Neurocognitive disturbances 
Cognitive impairment can be associated with epilepsy and adds to disability beyond 
seizures alone, particularly in those with temporal lobe epilepsy and drug-resistant 
epilepsy122, 123. The details of cognitive assessment and training in epilepsy were thoroughly 
discussed in separate recommendation statements124. Instead of providing rehabilitation or 
training that targets objective cognitive deficits, psychological treatments may aim at 
managing the interrelationship between mood, anxiety and subjective cognitive complaints, 
which may not necessarily be reflected in objective evidence of cognitive impairment125.  
3.7a Evaluation of the evidence for interventions for neurocognitive disturbances. 
Only one RCT investigated a psychological intervention specifically focused on cognitive 
symptoms (LOE III)85, and one other study86 measured cognitive functions as secondary 
outcome (LOE II). The highest level of evidence pertains to a mindfulness-based training for 
individuals with epilepsy, aiming to cultivate patients’ self-awareness and focused attention. 
The completion of this treatment was associated with significant improvements in objective 
measures of delayed verbal memory in patients with drug-resistant epilepsy compared to 
controls86; however, no changes were reported in other cognitive measures, including 
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attention, non-verbal memory and executive functions. A home-based self-management 
program (HOBSCOTCH) incorporating psychoeducation, self-awareness training, 
compensatory strategies and cognitive training has been developed and has been shown to be 
associated with significant improvement in objective cognitive performance85. 
Using Acceptance and Commitment Therapy tailored for individuals with epilepsy, 
Lundgren et al. (2006; 2008) guided individuals to develop a non-judgmental acceptance of 
their memory functions and refocused patients on the achievement of valued life goals 
despite the preconceived obstacle of impaired cognitive functioning109, 110. In a controlled 
study (LOE IV), this intervention was found to be associated with significantly improved 
HRQOL109, 110.  
3.7b Interventions for neurocognitive disturbances in epilepsy receive a GRADE 
recommendation of STRONG: There is moderate- to high-quality evidence that 
mindfulness-based interventions produce a clinically meaningful effect on neurocognitive 
disturbances in individuals with epilepsy. 
3.7c Considerations for pediatric populations. The prevalence of Attention-
Deficit/Hyperactivity Disorder (ADHD) is higher in pediatric epilepsy than in the general 
population, with rates of 30-40% in children with epilepsy126. There are very few studies 
examining the benefit of psychological interventions for children with epilepsy and comorbid 
ADHD127 and our search did not yield RCTs of psychotherapy for epilepsy and ADHD. 
Expert reviews on treatment of ADHD in individuals with epilepsy emphasizes the need to 
address cognition128. Moreover, the general child literature has a strong evidence base for the 
efficacy of behavioral interventions in reducing ADHD symptoms in children129. Given the 
comorbid learning disabilities and the neurocognitive deficits common in children with 
epilepsy, it is also important to discuss potential learning problems, provide access to 
resources (e.g., educational interventions), communicate with school personnel, and facilitate 
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referrals for neuropsychological evaluations. Commercially available products have also been 
recently tested in epilepsy and may prove to be beneficial130. A new web-based executive 
functioning intervention for adolescents is currently being tested and may be one way to aid 
youth with epilepsy around cognitive skill deficits131. 
3.7d Specific clinical recommendations for neurocognitive disturbances.  
1. Clinicians are encouraged to be aware of the interrelationship between mood, anxiety 
and subjective cognitive complaints, which may not necessarily be reflected in 
objective evidence of cognitive impairment.  
2. Cognitive assessment and training may complement a mindfulness-based training 
aiming to increase patients’ self-awareness and focused attention. 
3. Several strategies can be built into psychological interventions for individuals with 
epilepsy with subjective neurocognitive disturbances to enhance a sense of self-
reliance. These techniques include incorporating written handouts, joint reviews of the 
preceding sessions to reinforce memory for session content, shortening treatment 
sessions, and audio-recording sessions to enable the individuals to review the content 
between sessions. Such techniques have been found to be beneficial77.  
4. In the absence of data to support the efficacy of behavioral interventions tailored to 
children with epilepsy and ADHD, clinicians are encouraged to apply the evidence-
based behavioral techniques supported in the general child literature. 
3.8 Social and family problems and stigma  
Having epilepsy may be associated with vocational, educational, social and personal 
difficulties132. Indeed, individuals with epilepsy are less likely to be well educated, employed, 
and/or and have a romantic partner133. They also experience social difficulties, including 
social isolation, social competence, and other social skills deficits134. Family functioning, 
including communication, social support, adaptation, mastery, and conflict is often impacted 
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by epilepsy135. Personal experiences with epilepsy may involve perceived stigma, defined as 
a set of negative and often unfair beliefs about something136. Perceptions of stigma can lead 
to concealment in order to avoid the anticipated negative consequences of epilepsy disclosure 
in societies at all stages of economic development120, 137. While the strength of the perception 
of stigma may be associated with internal factors, such as low self-esteem132, there are also 
external factors, including cultural and religious differences contributing to stigma138. The 
extent to which independence and autonomy are encouraged also varies considerably 
between cultures. Regardless of these cultural differences, epilepsy may result in significant 
restrictions in an individual’s social functioning and independence, which may be self-
imposed or imposed by others61. 
3.8a Evaluation of the evidence for interventions for social and family problems and 
stigma. Regardless of their primary outcome measure, most psychological treatments employ 
strategies to actively strengthen the social network and build social support, to limit 
overprotection or inappropriate dependence and to enhance self-responsibility, to improve 
communication and the acceptance of the diagnosis and deal with emotional difficulties. 
Specific to the social domain, one LOE I psychological intervention study emphasized social 
skills84, while one LOE II psychological intervention study focused on social activation75, 76, 
and one LOE II self-management intervention focused on community integration and 
optimizing epilepsy-related communication89. A LOE II intervention incorporated family 
components to adherence and utilized an outcome measure that included an aspect of family 
functioning- parenting (child support, autonomy, discipline)104. LOE III and IV psychological 
interventions included assertion training81, communication skills77, identification of social 
support80, anger management87 and motivational interviewing 139. LOE II educational 
programs included information about social, family and occupational issues53, 55, and LOE III 
educational programs included content/skills for communication, self-responsibility, and self-
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management57, self-advocacy topics62, coping59, 60, as well as psychosocial and occupational 
issues58. One LOE IV educational program in Nigeria65 addressed specific cultural 
misconceptions about seizures and their treatment. Of note, most of the interventions 
addressing family components are targeted towards pediatric patients and their caregivers, 
and none of the identified studies measured outcomes relating explicitly to stigma.  
3.8b Interventions for social and family problems and stigma in epilepsy receive a 
GRADE recommendation of STRONG: There is moderate- to high-quality evidence that 
psychological interventions, adherence and self-management interventions produce a 
clinically meaningful effect on symptoms related to social and family problems and stigma. 
3.8c Considerations for pediatric populations. Children and adolescents with epilepsy 
are at greater than average risk of having increased dependence on parents140. Parents are 
often overly restrictive and overprotective of their children with epilepsy, which can 
influence social growth and independence141, 142.  
3.8d Specific clinical recommendations for social problems and stigma  
1. Clinicians should inquire about the extent to which individuals with epilepsy feel 
affected by interpersonal and social problems, including problems affecting 
individuals with epilepsy at their workplace, in school or in their private lives 
2. This assessment may include evaluation of barriers to open communication about 
epilepsy to avoid anticipated negative consequences of disclosure  
3. Incorporate treatment components that address internal factors contributing to social 
and family problems and stigma such as social and communication skills (e.g. 
assertion training, training of epilepsy-related communication), social activation (e.g. 
community integration, identification of social support), and parenting skills.  
4. Treatment delivery and service considerations  
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The described treatment elements may be delivered face-to-face or via telehealth 
technology (e.g., computer, smartphone, tablet, telephone) in an individual or group setting or 
in a combination of these modalities.  
4.1a Evaluation of the treatment delivery and implementation modalities.  
A group setting used by itself or as an adjunct to individual sessions may not only be 
more cost-effective than individual sessions, it also offers some unique advantages such as 
group role modeling to practice skills and the solicitation and exchange of individual 
experiences, perspectives and self-management strategies. Group interventions were 
investigated by one LOE I psychological intervention study84, one LOE II psychological 
intervention study86, and one LOE II self-management intervention study89. All of these 
studies reported significant improvements in their primary outcome measures. Over half of 
all investigated educational interventions were delivered in a group setting55, 57, 58, 59, 62, 63, 64, 
65.  
In addition to the face-to-face delivery by trained health professionals, telehealth options 
have been explored in one LOE II psychological intervention study79 investigating a web-
based treatment aiming to decrease depressive symptoms (Deprexis), one LOE IV web-based 
self-management program (WebEase)106, and one LOE IV SMS-based educational program 
(Mobile Epilepsy Educational System, MEES)61. Interactive engagement can be promoted by 
questions and quizzes79, 106 or the opportunity to send personal inquiries that are answered by 
program providers61, which allows for the personalized delivery of educational materials 
(e.g., tailoring). One LOE IV study80 investigated the telephone-based delivery of a 
psychological intervention in a group setting. All of these aforementioned studies reported 
significant results regarding their primary outcome measures. Since limited access to 
psychological treatments that are specifically designed to address the needs and concerns of 
people with epilepsy seems be the rule rather than the exception143, telehealth modalities may 
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help break down barriers to delivering psychological treatments in some resource-poor 
settings and help facilitate treatment for individuals with active seizures who live in areas 
with poor public transportation. Some studies in pediatric epilepsy suggest that telehealth 
modalities have similar outcomes and therapeutic alliance as face-to-face interventions144, 145. 
In fact, a meta-analysis found no differences between face-to-face and telehealth in the 
general population146. Similarly, home-based delivery of multimodal interventions may 
eliminate barriers and promote the collaboration between community/public health care 
professionals and epilepsy specialists. One LOE II study75, 76 and one LOE III study85  
reported significant improvements in primary outcomes 
Optimal treatment implementation remains an ongoing area of development. Since the 
development of new skills and the formation of new habits requires time and regular practice, 
most interventions aim to increase participants’ practice of relevant skills by embedding 
knowledge into treatment sessions spread out over time. Education protocols can, for 
example, either be delivered en bloc as a two-day course or in a weekly format. Half of all 14 
studies investigating educational programs53, 54, 55, 61, 62, 63, 66 had chosen to deliver their 
interventions using at least two sessions that were at least one month apart. LOE I and II 
studies of psychological interventions and one self-management intervention89 reporting 
significant primary outcome results were implemented in at least four sessions86 that were 
delivered with a maximum frequency of weekly sessions84 and a minimum frequency of two 
to three weeks between sessions75, 76. Depending on their primary treatment method, these 
interventions included practice assignments between sessions. Booster sessions following a 
more intense treatment period may increase skills retention109, 110.  
4.1b Home-based, group-based and telehealth intervention delivery in epilepsy 
receive a GRADE recommendation of STRONG: There is moderate- to high-quality 
evidence that home-based, group-based and telehealth-based treatments produce a clinically 
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meaningful effect on a broad range of symptoms in individuals with epilepsy, including 
suicidal ideation and depressive symptoms, as well as HRQOL. 
4.1c Considerations for pediatric populations. Electronic and telehealth treatment 
modalities (e.g., telephone, computer, mobile health, electronic health) may be particularly 
beneficial to families of children with epilepsy, who must consider balancing the needs of the 
child with epilepsy and other children, difficulty taking time off from work/school, etc. to 
engage in psychological treatment. Adolescents have a strong preference for technology and 
are thus also more likely to be amenable to telehealth treatment modalities147.  
4.1d Specific clinical recommendations for treatment delivery and implementation 
1. The described treatment elements may be delivered face-to-face in clinical settings or 
home-based, via telehealth technology.  
2. Psychological interventions can be provided individually or in a group format.  
3. Clinicians are encouraged to choose treatment delivery modalities based on local 
treatment resources (e.g. community/public health care professionals) and barriers 
(e.g. poor public transportation). 
4. A group setting may be more cost-effective than individual sessions and offer unique 
advantages (e.g. exchange of individual experiences, elicitation of group support and 
encouragement). 
5. While it is beyond the scope of this paper to discuss the differences in treatment 
implementation and delivery across cultures, we encourage the implementation of 
basic elements of psychological interventions, including education and self-help 
resources (including, e.g., relaxation CDs, seizure tracking devices etc.) 
6. While providers and patients may wish to compress intervention content, they are 
encouraged to consider the dose(s) of treatments suggested by the empirical literature 
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to permit sufficient scope for consolidating change by including practice by 
participants between sessions. 
7. In order to decrease anxieties in non-medical mental healthcare professionals over 
treating patients with seizures, a protocol should be generated for individual patients, 
detailing how seizures that may occur during treatment sessions should be managed. 
5.  Training recommendations  
Mental health providers who have had extensive professional training in the delivery of 
psychological interventions may have greater capacity to deliver psychological treatment for 
people with epilepsy than epilepsy-specific providers who have had very limited (if any) 
training in providing non-educational psychological interventions. Medical professionals, 
such as epilepsy nurses are equipped to provide educational and basic self-management 
interventions and can be equipped for other psychological interventions (cognitive 
behavioral, mindfulness) with specific training (e.g., psychiatric nursing degree, completed 
training on a specific treatment protocol). Thus, we would recommend the following: 
1. It is important to acknowledge that the required training for specific interventions 
depends on the professional background and expertise of the person delivering the 
intervention, the nature of the treatment package, and how well the treatment has been 
described and manualized. 
2. A mental health professional delivering the intervention elements should have basic 
knowledge regarding epilepsy – etiology and classification of seizures, treatment 
options and psychopathology26.  
3. Conversely, a medical professional delivering any psychological intervention 
elements should receive training in the administration of psychological interventions 
in general as well as specific, detailed training in the implementation of the specific 
intervention protocol being administered. 
Michaelis     28 
 
4. Epilepsy-specific psychological interventions should ideally be implemented by 
professionals in direct contact with the diagnostician and the treating medical epilepsy 
specialist.  
5. Some interventions, such as PEARLS, UPLIFT, or MOSES/FAMOSES, offer and 
require the completion of program-specific training prior to implementation, with 
variability in the extent and mode of training58, 59, 60, 75, 76, 80, 83, 148, 149, 150 to ensure the 
treatment is delivered as intended. 
Conclusion 
All patients should be screened for mental health comorbidities, and patients with 
psychological symptoms should be referred for further evaluation and treatment of indicated 
or at-risk psychological symptoms. Evidence supports that psychological therapies which 
target comorbid mental health symptoms and HRQOL should be considered in the 
comprehensive treatment of individuals with epilepsy. The strongest evidence was identified 
for the most common mental health problems, including depression, as well as health 
behaviors, such as adherence. Treatments for these disorders and challenges received 
STRONG recommendations. Treatment protocols and training on the intervention techniques 
and delivery is available for many of the interventions discussed. Few treatments have been 
evaluated with the same rigor in children and adolescents compared to adults, and we lack 
studies focusing on anxiety as an intervention target and primary outcome. In addition, RCTs 
investigating psychological interventions in other common comorbidities, such as ADHD and 
substance abuse in adults and children with epilepsy, are absent. However, there is a strong 
evidence base for the benefit of psychological interventions in treating these disorders in the 
general population, which can be used to inform the development of epilepsy specific 
intervention protocols and RCT designs to evaluate the efficacy of these interventions in the 
epilepsy population. Epilepsy health care providers are encouraged to promote psychological 
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treatments as an integral part of epilepsy care and to know the resources available in their 
area.  
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Figure 1: Flow chart of study selection 
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Table 1: Terminology for psychological interventions 
Intervention Goal Type of Therapies Used 
Psychological 
interventions 
 
 
 
• To reduce psychological distress 
(e.g., depressive or anxiety 
symptoms) 
• To improve adjustment and coping 
with epilepsy and its treatments 
• Cognitive-behavioral therapies 
• Behaviorally-based therapies 
• Acceptance and Commitment 
Therapy 
• Motivational interviewing 
Self-/family 
management 
and adherence 
intervention 
 
• Activities or steps that an individual 
or family can perform that are 
known to either influence the 
frequency of seizures or promote the 
well-being of the person with 
seizures.  
• Activities or steps can lie within the 
individual, family, community, or 
healthcare system domains  
• Cognitive-behavioral  
• Motivational interviewing 
• Family therapy 
Adherence 
interventions 
• Helping patients adhere to the advice 
of healthcare providers, including 
taking antiepileptic drugs, following 
a ketogenic diet, and avoiding 
seizure triggers.  
• Medication taking can be broken 
down into several components, 
including optimal dose timing and 
adequate frequency of dosing. 
• Problem-solving 
• Intention 
• Motivational interviewing 
• Family therapy 
 
Educational 
interventions 
• Increase knowledge of epilepsy and 
its treatments or the working of the 
brain  
• Psychoeducation (group or 
individual formats) 
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Table 2. Modified GRADE recommendations for psychological treatments based on systematic 
reviews (adapted from Guyatt et al., 2008) 
Recommendation 
Very strong 
recommendation 
 
All of the following: 
• There is high-quality evidence that the treatment produces a clinically 
meaningful effect on symptoms of the disorder being treated. 
• There is high-quality evidence that the treatment produces a clinically 
meaningful effect on functional outcomes. 
• There is high-quality evidence that the treatment produces a clinically 
meaningful effect on symptoms and/or functional outcomes at least 3 
months after treatment discontinuation. 
• At least one well-conducted study has demonstrated effectiveness in non-
research settings. 
Strong 
recommendation 
At least one of the following: 
• There is moderate- to high-quality evidence that the treatment produces a 
clinically meaningful effect on symptoms of the disorder being treated. 
• There is moderate- to high-quality evidence that the treatment produces a 
clinically meaningful effect on functional outcomes. 
Weak 
recommendation 
Any of the following: 
• There is only low- or very low-quality evidence that the treatment 
produces a clinically meaningful effect on symptoms of the disorder 
being treated. 
• There is only low- or very low-quality evidence that the treatment 
produces a clinically meaningful effect on symptoms of the disorder being 
treated as well as on functional outcomes. 
• There is moderate- to high-quality evidence that the effect of the treatment, 
although statistically significant, may not be of a magnitude that is 
clinically meaningful. 
 
Table 2: The recommendations are either rated as very strong, strong or weak. 
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Table 3: AAN LOE of studies investigating psychoeducation  
 
Study  
Treatment 
method 
Primary 
outcomes 
Secondary 
outcomes 
Blinding Randomization 
Concealed 
Allocation 
Masked 
Assessment  
Attrition  
AAN 
LOE 
E
d
u
ca
ti
o
n
a
l 
In
te
rv
en
ti
o
n
s 
Aliasgharpour 
2012 (63) 
E
p
il
ep
sy
 (
p
sy
ch
o
-)
ed
u
ca
ti
o
n
 p
ro
g
ra
m
  
ESMS ↑    ?  ?   
Class 
IV 
Dash 2015 (53) MMAS ↑       
Class 
II 
Helgeson 1990 
(64) 
Misinformation 
about epilepsy 
↓ 
Fear of 
seizures ↓ 
 ?  ?  ?   
Class 
IV 
Jantzen 2009 (57) DISABKIDS ↑ 
Disclosure 
of epilepsy 
↑ 
     
Class 
III 
Lua 2013 (61) MQOLIE-30 ↑  ?   ?  ?   
Class 
IV 
May 2002 (58) SF-36 ↔ D-S' ↔      
Class 
III 
Olley 2001 (65) 
Knowledge 
about illness ↑ 
BDI ↓     ?  
Class 
IV 
Pfäfflin 2012 (60) 
Epilepsy 
knowledge ↑ 
      
Class 
III 
Pramuka 2007 
(62) 
QOLIE-89 ↔    ?    
Class 
IV 
Rau 2006 (59) KINDL ↔ 
Seizure 
frequency 
↔ 
     
Class 
III 
Ridsdale 2000 
(66) 
Satisfaction 
with advice ↑ 
Knowledge 
of epilepsy  
↔ 
     
Class 
IV 
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Yadegray (2015) 
(67)  
QOLIE-31-P ↑  ?  ? ? ? 
Class 
IV 
Pfäfflin 2016 (55) Counseling 
Satisfaction 
with 
information 
and support ↑ 
QOLIE-31 
↔, HADS-
D ↔, 
HADS-A 
↔ 
     
Class 
II 
Beretta 2014 (54) 
Patient-
tailored 
medication 
education 
Drug-related 
problems ↓ 
QOLIE-31 
↔ 
     
Class 
II 
M
ix
ed
 
Helde 2005 (56) 
Epilepsy 
education 
+Nurse-led 
counseling 
QOLIE-89 ↑       
Class 
II 
 
Table 3: ↑: significant increase, ↓: significant decrease, ↔: result was not significant; red ↑: high risk of bias, green ↓: low risk of bias, yellow ↔: unclear risk 
of bias; AAN: American Academy of Neurology, BDI: Beck Depression Inventory, D’s: Depressive Mood Scale, DISABKIDS: Quality Of Life in children 
and adolescents with disabilities and their family, ESMS: Epilepsy Self-Management Scale, HADS-D/A: Hospital Anxiety Depression Scale-
Depression/Anxiety, KINDL: Gesundheitsbezogene Lebensqualität und psychosoziale Auswirkungen der Epilepsie (Health-related Quality of Life and 
psychosocial consequences of epilepsy), LOE: Level of Evidence, MMAS: modified Morisky Medication Adherence Scale, MQOLIE-30: Malay Quality of 
Life Inventory in Epilepsy-30, QOLIE-31/-31-P/-89: Quality of Life Inventory in Epilepsy-31/-31-P/-89, SF-36: Short-Form 36 
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Table 4: AAN LOE of studies investigating interventions investigating depression and anxiety 
 Study 
Treatment 
method 
Primary 
outcomes 
Secondary 
outcomes 
Blinding Randomization 
Concealed 
Allocation 
Masked 
Assessment 
Attrition 
AAN 
LOE 
P
sy
ch
o
lo
g
ic
a
l 
T
re
a
tm
en
ts
  
Ciechanowski 2010 
& Chaytor 2011 (75 
& 76) 
C
o
g
n
it
iv
e 
B
eh
av
io
ra
l 
T
h
er
ap
y
 (
C
B
T
) 
 
HSCL-20 
↔, suicidal 
ideation ↓ 
      
Class 
II 
Davis 1984 (81) 
DACL ↓, 
BDI ↔ 
  ?  ?  ?   
Class 
IV 
Gandy 2014 (77) 
NDDI-E ↓, 
HADS-D ↓ 
HADS-A 
↔,  
     
Class 
IV 
Martinovic 2006 
(84) 
BDI ↓, CES-
D ↓, HAMD 
↓ 
      Class I 
Orjuela-Rojas 2015 
(78) 
BDI ↓, 
HADS-D 
↔, MINI ↔ 
HADS-A 
↔ 
     
Class 
III 
Schröder 2014 (79) BDI ↓       
Class 
II 
Tan 1986 (88)  
BDI ↔, 
MMPI ↔ 
 ?  ?  ?   
Class 
IV 
Thompson 2010 
(80) 
BDI ↓   ?   ?   
Class 
IV 
Thompson 2015 
(83) 
BDI ↓, 
NDDI-E ↓ 
  ?  ?  ?   
Class 
IV 
Li 2016 (82) 
Systemic 
family 
therapy 
(SFT) 
HADS-D/-A 
↓ 
 ?  ?  ?  ?  ?  
Class 
IV 
Tang 2015 (86) 
Mindfulness 
Therapy 
(MT) 
 BAI ↓, BDI 
↓  
     
Class 
II 
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Tajrishi 2015 (87) 
Attribution 
retraining 
↓ GHQ   ?  ?  ?  ?  
Class 
IV 
S
el
f-
M
a
n
a
g
em
en
t 
Fraser 2015 (89) 
Comsumer-
driven 
Psycho- 
education 
 PHQ-9  ↓      
Class 
II 
P
sy
ch
o
ed
u
ca
ti
o
n
 
Olley 2001 (65) 
Psycho- 
education 
 BDI ↓     ?  
Class 
IV 
Pfäfflin 2016 (55) Counseling  
HADS-D 
↔, HADS-
A ↔ 
     
Class 
II 
M
ix
ed
 
Caller 2016 (85)  
Cognitive, 
memory + 
self-
management 
training  
 PHQ-9 ↔, 
NDDI-E ↔ 
     
Class 
III 
Table 4: ↑: significant increase, ↓: significant decrease, ↔: result was not significant; red ↑: high risk of bias, green ↓: low risk of bias, yellow ↔: unclear risk 
of bias; BAI: Beck Anxiety Inventory, BDI: Beck Depression Inventory, CES-D: Center for Epidemiological Study on Depression scale, DACL: Depression 
Adjustment Checklist, ESMS: Epilepsy Self-Management Scale, GHQ: General Health Questionnaire, HAMD: Hamilton Depression Scale, HADS-A/-D: 
Hospital Anxiety Depression Scale, HSCL-20: Hopkins Symptom Checklist-20, MINI: Mini International Neuropsychiatric Interview, MMPI: Minnesota 
Multiphasic Personality Inventory, NDDI-E: Neurological Depressive Disorders Inventory-Epilepsy, PHQ-9: Patient Health Questionnaire-9 
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Table 5: AAN LOE of studies investigating interventions aiming at improving medication adherence 
 
 
Study  
Treatment 
method 
Primary 
outcomes 
Blinding Randomization 
Concealed 
Allocation 
Masked 
Assessment  
Attrition  AAN LOE 
S
el
f-
m
a
n
a
g
em
en
t 
In
te
rv
en
ti
o
n
s Dilorio 
2009 
(107) Motivational 
Interviewing (MI) 
AGAS ↔, 
MEMS ↔ 
     Class IV 
Dilorio 
2011 
(106) 
MAS ↑      Class II 
A
d
h
er
en
ce
 I
n
te
rv
en
ti
o
n
s Modi 
2016 
(104) 
Family-tailored 
problem-solving 
intervention 
MEMS ↑      Class II 
Pakpour 
2015 
(103) 
Motivational 
Interviewing (MI) 
MAS ↑ ?   ?  ?   Class IV 
Peterson 
1984 
(105) 
Counseling 
AED plasma 
levels ↑, 
prescription refill 
frequency ↑ 
  ?  ?   Class IV 
 
Table 5: ↑: significant increase, ↓: significant decrease, ↔: result was not significant; red ↑: high risk of bias, green ↓: low risk of bias, yellow ↔: unclear risk 
of bias; AGAS: Antiretroviral General Adherence Scale, MEMS: Medication Event Monitoring System, MAS: Medication Adherence Scale, MAS: 
Medication Adherence Scale 
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Table 6: AAN LOE of studies investigating intervention investigating seizure-related outcomes 
 
Study  
Treatment 
method 
Primary 
outcomes 
Secondary 
outcomes 
Blinding Randomization 
Concealed 
Allocation 
Masked 
Assessment  
Attrition 
AAN 
LOE 
 
Au 2003 (113) 
Cognitive 
Behavioral 
Therapy 
(CBT)  
Seizure 
frequency 
↔ 
 ?      
Class 
III 
Ciechanowski 2010 
& Chaytor 2011 (75 
& 76)  
 seizure 
frequency ↔ 
     
Class 
II 
Dahl 1985 (114) 
Seizure 
index ↓ 
  ?  ?    
Class 
IV 
Mc Laughlin 2011 
(116) 
Seizure 
frequency 
↓ 
   ?  ?   
Class 
IV 
Tan 1986 (88) 
Seizure 
frequency 
↔ 
  ?  ?  ?   
Class 
IV 
Lundgren 2006 
(109) 
Acceptance 
and 
Commitmen
t Therapy 
(ACT) 
 
Seizure 
frequency ↓, 
seizure index 
↓ 
     
Class 
IV 
Lundgren 2008 
(110) 
Seizure 
frequency ↓, 
seizure index 
↓ 
     
Class 
IV 
Li 2016 (82) 
Systemic 
family 
therapy 
(SFT) 
 Seizure 
frequency ↓ 
?  ?  ?  ?  ?  
Class 
IV 
Michaelis     39 
 
Tang 2015 (86) 
Mindfulness 
Therapy 
(MT) 
 
seizure 
frequency ↓, 
SSI ↔ 
     
Class 
II 
P
sy
ch
o
ed
u
ca
ti
o
n
 
May 2002 (58) 
Psychoeduc
ation 
 Seizure 
frequency ↓ 
     
Class 
III 
Rau 2006 (59)  
Seizure 
frequency ↔ 
     
Class 
III 
 
Table 6: ↑: significant increase, ↓: significant decrease, ↔: result was not significant; red ↑: high risk of bias, green ↓: low risk of bias, yellow ↔: unclear risk 
of bias; seizure index: (seizure frequency x seizure duration in seconds), SSI: Seizure Severity Index 
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